Literature DB >> 11843209

The use of antidepressant drugs in dermatology.

M A Gupta1, A K Guptat.   

Abstract

This paper provides an updated review of the use of antidepressant drugs in dermatology. Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life. Cutaneous symptoms may be the feature of a primary psychiatric disorder, e.g. cutaneous body image problems, dermatitis artefacta, neurotic excoriations and trichotillomania, or psychiatric syndromes may be comorbid with a primary dermatological disorder such as the association of major depressive disorder or social phobia with psoriasis and obsessive compulsive disorder with acne excoriee. Some of the salient pharmacological properties of the tricyclic antidepressants (TCAs) and the selective serotonin reuptake inhibitor (SSRI) antidepressants are reviewed. The review indicates that the SSRI antidepressants are potentially beneficial in the management of all the major psychiatric syndromes that are encountered in dermatological disorders. The generally more favourable side-effect profile of the SSRIs, such as lower cardiotoxicity in contrast to the TCAs, has made them the first-line agents for the treatment of depression. Furthermore, some of the pharmacological properties of the antidepressant agents that are not related to their antidepressant activity, such as the histamine H1 blocking effect of TCAs, such as doxepin, amitriptyline and trimipramine, are of benefit in dermatological conditions such as urticaria and pruritus. This paper reviews the general guidelines for use of antidepressants and salient drug-drug interactions resulting mainly from the inhibition of the cytochrome P450 (CYP) 2D6 and 3A3/4 isoenzymes by some of the SSRI antidepressants. Before prescribing an antidepressant agent, the specific guidelines, side-effect profile, drug-drug interactions and most current indications should always be obtained.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11843209     DOI: 10.1046/j.1468-3083.2001.00278.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  12 in total

Review 1.  [Antidepressant drugs : a reasonable therapy for pruritus?].

Authors:  U Raap; A Kapp; U Darsow
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

2.  Chronic pruritus: clinics and treatment.

Authors:  Sonja Grundmann; Sonja Ständer
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

3.  [Management of cutaneous lymphomas].

Authors:  J P Nicolay; C-D Klemke
Journal:  Hautarzt       Date:  2014-07       Impact factor: 0.751

4.  Defining risk factors for red man syndrome in children and adults.

Authors:  Angela L Myers; Andrea Gaedigk; Hongying Dai; Laura P James; Bridgette L Jones; Kathleen A Neville
Journal:  Pediatr Infect Dis J       Date:  2012-05       Impact factor: 2.129

Review 5.  Pharmacogenomics in dermatology: tools for understanding gene-drug associations.

Authors:  Roxana Daneshjou; Rachel Huddart; Teri E Klein; Russ B Altman
Journal:  Semin Cutan Med Surg       Date:  2019-03-01

6.  Dermatitis artefacta.

Authors:  Bimal Tamakuwala; Parag Shah; Kamlesh Dave; Ritambhara Mehta
Journal:  Indian J Psychiatry       Date:  2005-10       Impact factor: 1.759

7.  The Itch-Scratch Cycle: A Review of the Mechanisms.

Authors:  Giulia Rinaldi
Journal:  Dermatol Pract Concept       Date:  2019-04-30

8.  Dermatitis artefacta.

Authors:  Surajit Nayak; Basanti Acharjya; Basanti Debi; Sarada P Swain
Journal:  Indian J Psychiatry       Date:  2013-04       Impact factor: 1.759

9.  Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations.

Authors:  Eva Ritvo; James Q Del Rosso; Mark A Stillman; Christopher La Riche
Journal:  Biopsychosoc Med       Date:  2011-08-13

Review 10.  Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments.

Authors:  Lai-San Wong; Tiffany Wu; Chih-Hung Lee
Journal:  Int J Mol Sci       Date:  2017-07-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.